Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,000
Closed -$340K 7165
2021
Q4
$340K Buy
+10,000
New +$363K ﹤0.01% 5416
2021
Q3
Sell
-20,000
Closed -$1.3M 7004
2021
Q2
$1.3M Buy
+20,000
New +$1.27M ﹤0.01% 4421
2019
Q2
Sell
-10,000
Closed -$954K 4235
2019
Q1
$954K Buy
+10,000
New +$1.25M ﹤0.01% 2895

Other funds holding INGN

Israel Englander's INGN Position: Q2 2026 in Review

Israel Englander reduced its Inogen (INGN) stake by 73% in Q2 2026, selling an estimated $419K and leaving 23,568 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #5388.

Israel Englander first reported a position in INGN in Q1 2014 and has held it in 42 quarters since. The position peaked at $32.4M in Q4 2017. 128 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Israel Englander held 23,568 shares of Inogen worth $152K as of Q2 2026.
  • Israel Englander sold 63,382 Inogen shares in Q2 2026, an estimated $419K.
  • Inogen made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5388 holding.
  • Israel Englander first reported a position in Inogen in Q1 2014 and has held it in 42 quarters since.
  • Israel Englander's Inogen position peaked at $32.4M in Q4 2017.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.